355 / 1498
Key questions in using Combined Modality
Treatment in early stage HL
•
Is the initial gain in local control with RT offset by the long
term risks of RT ?
•
Do modern RT approaches with substantial reduction in field
size and RT doses maintain excellent initial control and reduce
late toxicities leading to improved long term survival over
chemotherapy alone ?